Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
Trial Information
Positron Emission Tomography (PET)Studies in Attention Deficit Disorder: Role of Dopamine
The purpose of this study is to determine if adults with
Attention Deficit/Hyperactivity Disorder (ADHD) have changes in the
brain chemical called dopamine. Participants with and without
Attention Deficit/Hyperactivity Disorder will be compared in this
research project. Three brain scans known as positron emission
tomographies (PET) will be used to examine the differences in
dopamine levels and dopamine genes in ADHD and non-ADHD
participants. The PET scan will involve injections of substances
used to increase the production of dopamine in the brain. This
project also includes blood draws and questionnaires. Treatment for
ADHD in not included as part of this project. These research-
related procedures are provided at no cost. Participants will also
be reimbursed for their time.
Compensation Provided
Patient Inclusion/Exclusion Criteria:
Participants with and without ADHD:
Ages 18-45
Participants with ADHD:
Meet criteria for ADHD
For participants with and without ADHD:
No present or past history of drug abuse
No other presence of psychiatric disorders
No medical conditions that may alter brain function
No heart disease or high blood pressure
Cannot participate if pregnant or breastfeeding.
No exposure to stimulant medication (like Ritalin, Adderall,
Dexedrine) within past 6 months.
Participants with ADHD:
No previous treatments for ADHD except for short treatment periods
of less than 2 months at least 6 months prior to starting the
study.
Robyn C Palmero, M.A.,CCRC
Mount Sinai Medical Center
One Gustave L. Levy Place
New York, NY 10029
Phone: 212-659-8833
Fax: 212-849-2690
EMail: robyn.palmero@mssm.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
